Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Is Teva considering a $34B Mylan buyout to offset Copaxone losses?
Is Teva considering a $34B Mylan buyout to offset Copaxone losses?
Is Teva considering a $34B Mylan buyout to offset Copaxone losses?
Submitted by
admin
on April 20, 2015 - 11:59am
Source:
BioPharma Dive
News Tags:
Teva Pharmaceutical
Mylan
M&A
Copaxone
Headline:
Is Teva considering a $34B Mylan buyout to offset Copaxone losses?
Do Not Allow Advertisers to Use My Personal information
